摘要
目的探讨甲状腺癌患者血清肿瘤坏死因子-α(TNF-α)和白细胞介素-17(IL-17)水平与疾病病理状态及患者生活质量的关系。方法选取90例甲状腺癌患者,利用酶联免疫吸附方法(ELISA)检测血清TNF-α和IL-17水平,比较不同病理条件下的水平差异。采用肿瘤患者生活质量评分(QOL)标准对患者进行评分,探讨患者TNF-α和IL-17水平与其生活质量及肿瘤预后的关系。结果甲状腺癌淋巴结转移患者TNF-α和IL-17水平均显著增高,二者水平随着TNM分期的增高或细胞分化程度的降低亦均显著升高;患者QOL数值与其血清中TNF-α和IL-17水平均呈负相关;TNM分期、TNF-α和IL-17血清水平是疾病预后不良的独立危险因素。结论甲状腺癌患者血清TNF-α和IL-17水平与其临床病理状态及生活质量密切相关,是该病预后不良的危险因素。
Objective To investigate the relationship between serum tumor necrosis factor-α(TNF-α)and interleukin-17(IL-17)levels and disease pathological status and quality of life in patients with thyroid cancer.Methods Ninety patients with thyroid cancer were enrolled.The levels of serum TNF-αand IL-17 were measured by enzyme-linked immunosorbent assay(ELISA),and the differences in pathological conditions were compared.Patients were scored using the Quality of Life Score(QOL)criteria for cancer patients to investigate the relationship between TNF-αand IL-17 levels and their quality of life and tumor prognosis.ResultsThe levels of TNF-αand IL-17 in lymph node metastasis of thyroid carcinoma were significantly increased.The levels of TNM and the degree of cell differentiation were significantly increased.The QOL values of patients and their serum TNF-αand IL-17 levels were negatively correlated;TNM stage,TNF-αand IL-17 serum levels were independent risk factors for poor prognosis.Conclusion The levels of serum TNF-αand IL-17 in patients with thyroid cancer are closely related to their clinicopathological status and quality of life,which is a risk factor for poor prognosis of this disease.
作者
郭富饶
姜欢
戴微微
何德英
GUO Furao;JIANG Huan;DAI Weiwei;HE Deying(Banan People′s Hospital of Chongqing,Chongqing 401320,China)
出处
《国际检验医学杂志》
CAS
2018年第17期2163-2165,2174,共4页
International Journal of Laboratory Medicine